4//SEC Filing
Singh Vanila 4
Accession 0001103021-22-000024
CIK 0001103021other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:05 PM ET
Size
11.7 KB
Accession
0001103021-22-000024
Insider Transaction Report
Form 4
Singh Vanila
Director
Transactions
- Award
Stock Options (right to buy)
2022-01-27+85,760→ 85,760 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (85,760 underlying) - Award
Restricted Stock Units
2022-01-27+15,369→ 15,369 totalExercise: $0.00Exp: 2023-01-27→ Common Stock (15,369 underlying) - Exercise/Conversion
Restricted Stock Units
2022-01-27−7,684→ 7,685 totalExercise: $0.00Exp: 2023-01-27→ Common Stock (7,684 underlying) - Exercise/Conversion
Common Stock
2022-01-27+7,684→ 35,851 total
Footnotes (3)
- [F1]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan ("the Plan"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
- [F2]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F3]The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001795397
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:05 PM ET
- Size
- 11.7 KB